Abstract:
THE TREATMENT OR PREVENTION OF GASTRO-ENTERITIS DIARRHEAL SYNDROME (IDARRHEA) IN A LIVING ANIMAL BODY IS ACCOMPLISHED BY ORALY ADMINISTERING TO SAID ANIMAL BODY A THERAPEUTICALLY EFFECTIVE AMOUNT OF A BASIC POLYELECTROLYTE POLYMER, WHICH IS (A) A POLYMERIZED UNSATURATED CARBOXYLIC ACID OR ANHYDRIDE AND A DERIVATIVE OF A POLYMERIZED UNSATURATED CARBOXYLIC ACID OR ANHYDRIDE, (B) A DERIVATIVE OF A POLYMERIZED UNSATURATED CARBOXYLIC ACID OR ANHYDRIDE OR (C) A COPOLYMER OF (1) AN UNSATURATED MONOMER HAVING 2 TO 18 CARBON ATOMS AND (2) A MONOMER SELECTED FROM THE GROUP CONSISTING OF (A) AN UNSATURATED CARBOXYLIC ACID OR ANHYDRIDE AND A DERIVATIVE OF AN UNSATURATED CARBOXYLIC ACID OR NHYDRIDE AND (B) A DERIVATIVE OF AN UNSATURATED CARBOXYLIC ACID OR ANHYDRIDE, AS EXEMPLIFIED BY N,N-DIMETHYLAMINOPROPYLIMIDE OF ETHYLENE/MALEIC ANHYDRIDE COPOLYMER. THE BASIC POLYMER IS POLYCATIONIC OR POLYAMPHOLYTIC IN NATURE. TYPICAL DOSAGE IS 0.05 TO 5.0% OF THE TOTAL DIET.